[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354573-105":59,"doc-detail-354573-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","a-comparative-study-of-cdo1-promoter-methylation-in-gastric-cancer-and-h-pylori-associated-chronic-gastritis-implications-for-diagnostic-performance","A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis - Implications for diagnostic performance","","Silencing of the Cysteine dioxygenase-1 (CDO1) tumor suppressor gene by aberrant DNA methylation contributes to gastric carcinogenesis. This study compared CDO1 promoter methylation in chronic gastritis patients with and without Helicobacter pylori infection, and contrasted findings with gastric tumors. Quantification used methylation-specific PCR after bisulfite conversion and CDO1 immunohistochemistry in 45 tumors, 17 H. pylori-positive biopsies, 23 H. pylori-negative biopsies, and 15 controls. CDO1 methylation was higher in gastric cancer and also elevated in H. pylori-positive chronic gastritis, while immunopositivity did not differ. ROC analysis showed strong discrimination for cancer versus non-cancer (AUC=0.83) and limited ability for separating cancer from H. pylori-positive gastritis (AUC=0.67), suggesting biomarker potential but insufficient standalone value in high-risk inflammation.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comparative-study-of-cdo1-promoter-methylation-in-gastric-cancer-and-h-pylori-associated-chronic-gastritis-implications-for-diagnostic-performance/354573/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comparative-study-of-cdo1-promoter-methylation-in-gastric-cancer-and-h-pylori-associated-chronic-gastritis-implications-for-diagnostic-performance/354573.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of evaluating CDO1 promoter methylation in this study?","Question",{"text":113,"@type":114},"The study investigated whether CDO1 promoter methylation differs among gastric cancer, H. pylori-associated chronic gastritis, and H. pylori-negative chronic gastritis, and assessed implications for diagnostic performance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were CDO1 promoter methylation levels measured?",{"text":118,"@type":114},"CDO1 promoter methylation was quantified using quantitative methylation-specific PCR after bisulfite conversion.",{"name":120,"@type":111,"acceptedAnswer":121},"What diagnostic performance did the study report for CDO1 methylation?",{"text":122,"@type":114},"ROC analysis showed good discrimination between gastric cancer and non-cancer cases (AUC=0.83), but more limited performance for distinguishing gastric cancer from H. pylori-associated chronic gastritis (AUC=0.67).",{"name":124,"@type":111,"acceptedAnswer":125},"Did CDO1 immunohistochemistry results align with methylation findings?",{"text":126,"@type":114},"No significant differences in CDO1 immunopositivity were observed among the study groups, despite methylation differences.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},354573,1790190283,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nCitation: Kankaya S, Karatas M, Hatipoglu E, Kepil N, Kaptan Z, Caliskan Z, et al. (2026) A comparative study of CDO1 promoter methylation in gastric cancer and H. pyloriassociated chronic gastritis: Implications for diagnostic performance. PLoS One 21(8): e0335832. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0335832  \nEditor: Elingarami Sauli, Nelson Mandela African Institute of Science and Technology, TANZANIA, UNITED REPUBLIC OF  \nReceived: October 23, 2025  \nAccepted: July 28, 2026  \nPublished: August 12, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0335832  \nCopyright: © 2026 Kankaya et al. This is an open access article distributed under the terms  \nRESEARCH ARTICLE  \nA comparative study of CDO1 promoter methylation in gastric cancer and H. pyloriassociated chronic gastritis: Implications for diagnostic performance  \nSelin Kankaya1*, Metehan Karatas2, Engin Hatipoglu3, Nuray Kepil4, Zulal Kaptan5, Zeynep Caliskan1, Matem Tuncdemir2, Yildiz Dincer6  \n1 Department of Medical Biochemistry, Faculty of Medicine, Istanbul Yeni Yuzyil University, Istanbul, Turkey, 2 Department of Medical Biology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 3 Department of Surgical Medical Sciences, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 4 Department of Pathology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 5 Department of Physiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey, 6 Department of Medical Biochemistry, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey  \n* [selin.kankaya@yeniyuzyil.edu.tr](selin.kankaya@yeniyuzyil.edu.tr)  \nAbstract  \nSilencing of the Cysteine dioxygenase-1 (CDO1) tumor suppressor gene by aberrant DNA methylation contributes to gastric carcinogenesis. Despite evidence that Helicobacter pylori (H. pylori) infection induces aberrant DNA methylation in the gastric mucosa, CDO1 promoter methylation has not been well characterized in H. Pylori positive (HPP) patients with chronic gastritis. This study aimed to investigate the CDO1 promoter methylation levels in patients with chronic gastritis with and without H. pylori infection, in comparison with gastric tumors. The quantitative analysis of CDO1 promoter methylation and CDO1 immunopositivity was performed in 45 primary gastric tumors, 17 biopsy samples of HPP chronic gastritis, 23 H. Pylori negative (HPN) chronic gastritis, and 15 normal gastric mucosa samples (control group) . CDO1 expression was evaluated by immunohistochemistry, and promoter methylation levels were determined using quantitative methylation-specific PCR following bisulfite conversion. CDO1 promoter methylation levels were significantly higher in the gastric cancer (GC) group compared to the HPN chronic gastritis and control groups (p \u003C 0.001) . No significant difference was observed between the GC and HPP chronic gastritis groups. However, CDO1 promoter methylation levels were significantly higher in the HPP group compared to the HPN group (p = 0.049) . No significant differences in CDO1 immunopositivity were observed among the study groups. ROC analysis demonstrated good discriminative ability of CDO1 methylation between GC and non-cancer cases (AUC = 0.83), whereas its performance was more limited in distinguishing GC from HPP chronic gastritis (AUC = 0.67) . CDO1 promoter methylation is increased in GC and HPP chronic gastritis, suggesting that  \nPLOS One | [https://doi.org/10.1371/journal.pone.0335832](https://doi.org/10.1371/journal.pone.0335832) August 12, 2026 1 / 17  \nof the Creative Commons Attribution License, ","cbCaidwIw4GwaquP","https://ap.wps.com/l/cbCaidwIw4GwaquP","pdf",1221152,17,"English","# Abstract\n## Introduction\n## Methods and Measurements\n## Results\n## Conclusions\n## Data Availability and Declarations","[{\"question\":\"What was the purpose of evaluating CDO1 promoter methylation in this study?\",\"answer\":\"The study investigated whether CDO1 promoter methylation differs among gastric cancer, H. pylori-associated chronic gastritis, and H. pylori-negative chronic gastritis, and assessed implications for diagnostic performance.\"},{\"question\":\"How were CDO1 promoter methylation levels measured?\",\"answer\":\"CDO1 promoter methylation was quantified using quantitative methylation-specific PCR after bisulfite conversion.\"},{\"question\":\"What diagnostic performance did the study report for CDO1 methylation?\",\"answer\":\"ROC analysis showed good discrimination between gastric cancer and non-cancer cases (AUC=0.83), but more limited performance for distinguishing gastric cancer from H. pylori-associated chronic gastritis (AUC=0.67).\"},{\"question\":\"Did CDO1 immunohistochemistry results align with methylation findings?\",\"answer\":\"No significant differences in CDO1 immunopositivity were observed among the study groups, despite methylation differences.\"}]","A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis - Implications for diagnostic performance | PDF",1790112213,43,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc77839685378005d9927553ba503452.webp",983,1272,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0b157f6390a573afaa2e89cf2a592ac.webp",982,1270,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f49cb6e8fb28e6951fb2255fed199533.webp",981,1269,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8628ce6a2de5695a8c59a9d689a96b6e.webp",980,1268]